1-4 of 4
appendix rupture
Close
Sort by
Journal Articles

Immune Tolerance Induction (ITI) with a Plasma-Derived Factor VIII for Patients with Hemophilia a and Inhibitors: A Retrospective Study

Miguel A. Escobar, MD, Linda Shaffer, Mark Holguin, MD, Timothy McCavit, MD, Sandeep K. Rajan, MD, Novinyo Amega, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4923.
https://doi.org/10.1182/blood-2019-122949
Published: 2019
Journal Articles

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Reham Khedr, MD, Mohamed Abdel Waged, Marwa Fathy, MD, Wael Zekri, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5174.
https://doi.org/10.1182/blood-2018-99-114970
Published: 2018
Journal Articles

Final Results from a Phase I Combination Study of Lenalidomide and Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Mikkael A. Sekeres, MD, MS, Alan F. List, MD, David Cuthbertson, Ronald Paquette, MD, Deborah Latham, R.N., Manual Afable, R.N., Katarina Paulic, Thomas P. Loughran, Jr., MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 221.
https://doi.org/10.1182/blood.V112.11.221.221
Published: 2008
Journal Articles

Combination of Daunorubicin and Cytarabine Chemotherapy with Gemtuzumab Ozogamicin as Initial Therapy for Elderly Patients with Previously Untreated Acute Myeloid Leukemia.

Lisa A. Kujawski, MD, Irene Ryan, PA-C, Kent Griffith, MS, MPH, Harry P. Erba, MD, PhD.
Journal: Blood
Blood (2005) 106 (11): 4636.
https://doi.org/10.1182/blood.V106.11.4636.4636
Published: 2005